U
AGTC

UBS’s Applied Genetic Technologies Corporation AGTC Stock Holding History

UBS’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$15K Buy
811
+300
+59% +$5.43K ﹤0.01% 8385
2014
Q2 		$12K Buy
+511
New +$9K ﹤0.01% 8716

Other funds holding AGTC

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

UBS's AGTC Position: Q3 2014 in Review

UBS increased its Applied Genetic Technologies Corporation (AGTC) stake by 59% in Q3 2014, buying an estimated $5.43K and bringing the position to 811 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #8385.

UBS first reported a position in AGTC in Q2 2014 and has held it in 2 quarters since. 42 funds tracked by Wall St. Rank hold AGTC as of Q3 2014.

  • UBS held 811 shares of Applied Genetic Technologies Corporation worth $15K as of Q3 2014.
  • UBS bought 300 Applied Genetic Technologies Corporation shares in Q3 2014, an estimated $5.43K.
  • Applied Genetic Technologies Corporation made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8385 holding.
  • UBS first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and has held it in 2 quarters since.
  • 42 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.